Ligand Pharmaceuticals (LGNYZ) Receivables Refunds (2018 - 2025)
Historic Receivables Refunds for Ligand Pharmaceuticals (LGNYZ) over the last 9 years, with Q3 2025 value amounting to $536000.0.
- Ligand Pharmaceuticals' Receivables Refunds fell 9313.96% to $536000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $536000.0, marking a year-over-year decrease of 9313.96%. This contributed to the annual value of $4.1 million for FY2024, which is 3630.96% down from last year.
- As of Q3 2025, Ligand Pharmaceuticals' Receivables Refunds stood at $536000.0, which was down 9313.96% from $828000.0 recorded in Q2 2025.
- Over the past 5 years, Ligand Pharmaceuticals' Receivables Refunds peaked at $7.8 million during Q3 2024, and registered a low of $536000.0 during Q3 2025.
- For the 5-year period, Ligand Pharmaceuticals' Receivables Refunds averaged around $3.8 million, with its median value being $4.3 million (2025).
- In the last 5 years, Ligand Pharmaceuticals' Receivables Refunds skyrocketed by 17934.15% in 2021 and then plummeted by 9313.96% in 2025.
- Over the past 5 years, Ligand Pharmaceuticals' Receivables Refunds (Quarter) stood at $6.2 million in 2021, then decreased by 25.5% to $4.6 million in 2022, then surged by 38.6% to $6.4 million in 2023, then crashed by 36.31% to $4.1 million in 2024, then tumbled by 86.84% to $536000.0 in 2025.
- Its Receivables Refunds stands at $536000.0 for Q3 2025, versus $828000.0 for Q2 2025 and $4.3 million for Q1 2025.